USA Capacity Utilization Rate for Jun 80.000% vs 80.600% consensus estimate. The prior reading was 80.300%.
Intra-Cellular Therapies Q3 EPS $(0.95) Misses $(0.92) Estimate, Sales $22.21M Beat $22.12M Estimate
Intra-Cellular Therapies (NASDAQ:ITCI) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.92) by 3.26 percent. This is a 20.25 percent decrease over losses of $(0.79) per